C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL

Detalles Bibliográficos
Autores principales: TEMESGEN, ZELALEM, BURGER, CHARLES, BAKER, JASON, POLK, CHRISTOPHER, LIBERTIN, CLAUDIA, KELLEY, COLLEEN, MARCONI, VINCENT, ORENSTEIN, ROBERT, CATTERSON, VICTORIA, ARONSTEIN, WILLIAM, DURRANT, CAMERON, CHAPPELL, DALE, CHAPPELL, GABRIELLE, AHMED, OMAR, BADLEY, ANDREW
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Late Breaking
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503207/
http://dx.doi.org/10.1016/j.chest.2021.08.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503207/
http://dx.doi.org/10.1016/j.chest.2021.08.029

Ejemplares similares